Hologic (NASDAQ:HOLX – Free Report) had its price target upped by Needham & Company LLC from $83.00 to $90.00 in a research report report published on Friday morning, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. A number of other research analysts have also weighed in on HOLX. Raymond […]
Hologic (NASDAQ:HOLX – Get Free Report) updated its second quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.95 to $1.00 for the period, compared to the consensus estimate of $0.98. The company issued revenue guidance of $990 million to $1.010 billion, compared to the consensus revenue estimate of $994.39 […]
Barclays PLC cut its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 27.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 425,134 shares of the medical equipment provider’s stock after selling 157,628 shares during the period. Barclays PLC owned about […]
Hologic (NASDAQ:HOLX – Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.95 by $0.03, Briefing.com reports. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $989.32 million. Hologic had a return on […]
Qsemble Capital Management LP bought a new position in Hologic, Inc. (NASDAQ:HOLX – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,600 shares of the medical equipment provider’s stock, valued at approximately $1,152,000. A number of other hedge funds have also […]